Nobel Prize Honors Groundbreaking Body's Defenses Discoveries

This year's prestigious award in Physiology or Medicine was awarded for revolutionary discoveries that illuminate how the body's defense network attacks harmful infections while protecting the body's own cells.

A trio of renowned scientists—from Japan Prof. Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—share this honor.

The research uncovered unique "security guards" within the immune system that remove rogue defense cells capable of attacking the organism.

The findings are now paving the way for new treatments for autoimmune diseases and malignancies.

The laureates will divide a prize fund valued at 11m Swedish kronor.

Crucial Discoveries

"The research has been essential for comprehending how the body's defenses functions and why we do not all develop severe autoimmune diseases," stated the head of the award panel.

The team's research explain a core mystery: In what way does the immune system defend us from numerous infections while leaving our own tissues unharmed?

The immune system employs immune cells that search for indicators of disease, even pathogens and bacteria it has not met before.

These cells employ detectors—called receptors—that are produced by chance in countless combinations.

This provides the defense network the capacity to combat a wide array of invaders, but the randomness of the mechanism unavoidably creates white blood cells that can target the body.

Security Guards of the Body

Scientists earlier understood that some of these problematic defense cells were eliminated in the thymus—the site where immune cells mature.

The latest award honors the identification of regulatory T-cells—known as the body's "security guards"—which travel through the system to neutralize other immune cells that attack the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "The discoveries have laid the foundation for a novel area of investigation and spurred the development of innovative therapies, for instance for tumors and autoimmune diseases."

In cancer, T-regs prevent the body from fighting the tumor, so research are focused on reducing their quantity.

In autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A similar approach could also be useful in reducing the risks of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, from Osaka University, performed experiments on mice that had their immune gland removed, leading to autoimmune disease.

He demonstrated that introducing immune cells from other animals could stop the illness—implying there was a mechanism for preventing immune cells from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic autoimmune disease in mice and people that led to the identification of a gene critical for how T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a prominent physiology expert.

"This work is a striking illustration of how basic physiological study can have far-reaching consequences for human health."